The stock of healthcare services company Agilon Health (NYSE:AGL) surged by 29.9% during the afternoon trading session following Bernstein's upgrade of the stock's rating from Hold to Buy, setting a price target of $8.5. The firm's decision was based on positive new data regarding AGL, which boosted confidence in its turnaround strategies and financial position.

Closing at $5.36, the shares recorded a 26.1% increase from the previous close. The rise in AGL's stock price has drawn attention to the question of whether now is a good time to invest in Agilon Health.

Agilon Health's stock has shown high volatility, experiencing 80 movements greater than 5% over the past year. The significant impact of recent news on the market's perception of the company is evident in the stock's performance.

Although agilon health's shares have risen by 176% since the start of the year, trading at $5.30 per share, they remain 29.5% below their 52-week high of $7.52 in July 2024. Investors who bought $1,000 worth of agilon health's shares during the IPO in April 2021 would now see their investment valued at $170.96.

The increasing influence of generative AI on corporate operations is becoming more evident. The article suggests focusing on an under-the-radar semiconductor stock that is also benefiting from the AI trend rather than well-known options.